180 Life Sciences Engages Kinexum for Help in Making use of for Advertising and marketing Authorisation in the UK

180 Life Sciences Engages Kinexum for Help in Making use of for Advertising and marketing Authorisation in the UK

PALO ALTO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Firm”), immediately introduced that the Firm has engaged Kinexum, a strategic advisory agency, to assist the Firm in submitting a Advertising and marketing Authorisation Utility (MAA) for adalimumab to deal with progressive early-stage Dupuytren’s illness. […]

Continue Reading
180 Life Sciences Gives Replace on Progress To Search Medicines and Healthcare Merchandise Regulatory Company Advertising Authorization for Anti-TNF Remedy of

180 Life Sciences Gives Replace on Progress To Search Medicines and Healthcare Merchandise Regulatory Company Advertising Authorization for Anti-TNF Remedy of

PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Firm”), as we speak introduced that the Firm and its regulatory consultants from the US and the UK, met with the UK Medicines and Healthcare merchandise Regulatory Company (MHRA) scientific recommendation committee for the second […]

Continue Reading